FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004123655> ?p ?o ?g. }

• W2004123655 abstract "You have accessJournal of UrologyProstate Cancer: Basic Research V1 Apr 2010677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL Naoki Terada, Yosuke Shimizu, Tomomi Kamba, Takahiro Inoue, Atsushi Maeno, Takashi Kobayashi, Eijiro Nakamura, Toshiyuki Kamoto, Toshiya Kanaji, Takayuki Maruyama, Yoshiki Mikami, Yoshinobu Toda, Toshiyuki Matsuoka, Yasushi Okuno, Gozoh Tsujimoto, Shuh Narumiya, and Osamu Ogawa Naoki TeradaNaoki Terada Kyoto, Japan More articles by this author , Yosuke ShimizuYosuke Shimizu Kyoto, Japan More articles by this author , Tomomi KambaTomomi Kamba Kyoto, Japan More articles by this author , Takahiro InoueTakahiro Inoue Kyoto, Japan More articles by this author , Atsushi MaenoAtsushi Maeno Kyoto, Japan More articles by this author , Takashi KobayashiTakashi Kobayashi Kyoto, Japan More articles by this author , Eijiro NakamuraEijiro Nakamura Boston, MA More articles by this author , Toshiyuki KamotoToshiyuki Kamoto Miyazaki, Japan More articles by this author , Toshiya KanajiToshiya Kanaji Osaka, Japan More articles by this author , Takayuki MaruyamaTakayuki Maruyama Osaka, Japan More articles by this author , Yoshiki MikamiYoshiki Mikami Kyoto, Japan More articles by this author , Yoshinobu TodaYoshinobu Toda Kyoto, Japan More articles by this author , Toshiyuki MatsuokaToshiyuki Matsuoka Kyoto, Japan More articles by this author , Yasushi OkunoYasushi Okuno Kyoto, Japan More articles by this author , Gozoh TsujimotoGozoh Tsujimoto Kyoto, Japan More articles by this author , Shuh NarumiyaShuh Narumiya Kyoto, Japan More articles by this author , and Osamu OgawaOsamu Ogawa Kyoto, Japan More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1076AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Effective therapeutic approaches for castration-resistant prostate cancer (CRPC) are extremely limited and it is highly desirable to explore new therapeutic strategies based on a detailed understanding of molecular mechanisms for the progression to castration resistance. We have established a novel prostate cancer (PC) xenograft model, KUCaP-2, expressing wild-type androgen receptor (AR) and producing PSA. The xenograft tumors regress soon after castration and reproducibly regrow after 1-2 months without AR mutation, mimicking the clinical behavior of PC. The aim of the present study is to identify a novel therapeutic target against CRPC using this model. METHODS KUCaP-2 was established by the subcutaneous transplantation of local recurrent PC tumors into male nude mice. Xenograft tissues were collected during androgen-dependent growth (AD), castration-induced regression nadir (ND), and castration-resistant regrowth (CR) stages (n=4, each). Changes in gene expression profiles were examined using DNA microarray analysis. The expression levels of a candidate gene in 31 CRPC and 27 hormone-naïve PC (HNPC) clinical samples were examined by the immunohistochemistry and graded as none, weak, moderate and strong. Functional analyses of the candidate gene were performed using LNCaP cells. Effectiveness of the gene targeting therapy was investigated by the treatment against KUCaP-2. RESULTS The expression of prostaglandin E receptor EP4 subtype (EP4) was significantly up-regulated during the progression of castration resistance in KUCaP-2 tumors (ND/AD ratio=1.0; p=0.496, CR/ND ratio=15.7; p=0.029). In clinical samples EP4 expression grade of none/weak/moderate/strong were 10 (37%) / 17 (63%) / 0 (0%) / 0 (0%) in HNPC and 5 (16%) / 9 (29%) / 10 (32%) / 7 (22%) in CRPC patients (p=0.0001). EP4 over-expressing LNCaP (LNCaP-EP4) cells proliferated and produced PSA without androgen in vitro and in vivo. The androgen-independent proliferation of LNCaP-EP4 cells was suppressed when AR expression was attenuated using RNA interference. A specific EP4 antagonist, ONO-AE3-208, significantly decreased intracellular cAMP levels and suppressed PSA production of LNCaP-EP4 cells in vitro (100nmol/l) and decelerated castration-resistant growth of LNCaP-EP4 and KUCaP-2 tumors in vivo (10mg/kg/day/IP). CONCLUSIONS EP4 over-expression, via AR activation, is one of the mechanisms for the castration-resistant progression of PC and the EP4 antagonist is a novel therapeutic modality for the treatment of CRPC. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e264-e265 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Naoki Terada Kyoto, Japan More articles by this author Yosuke Shimizu Kyoto, Japan More articles by this author Tomomi Kamba Kyoto, Japan More articles by this author Takahiro Inoue Kyoto, Japan More articles by this author Atsushi Maeno Kyoto, Japan More articles by this author Takashi Kobayashi Kyoto, Japan More articles by this author Eijiro Nakamura Boston, MA More articles by this author Toshiyuki Kamoto Miyazaki, Japan More articles by this author Toshiya Kanaji Osaka, Japan More articles by this author Takayuki Maruyama Osaka, Japan More articles by this author Yoshiki Mikami Kyoto, Japan More articles by this author Yoshinobu Toda Kyoto, Japan More articles by this author Toshiyuki Matsuoka Kyoto, Japan More articles by this author Yasushi Okuno Kyoto, Japan More articles by this author Gozoh Tsujimoto Kyoto, Japan More articles by this author Shuh Narumiya Kyoto, Japan More articles by this author Osamu Ogawa Kyoto, Japan More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2004123655 created "2016-06-24" @default.
• W2004123655 creator A5007998286 @default.
• W2004123655 creator A5009433306 @default.
• W2004123655 creator A5024624058 @default.
• W2004123655 creator A5029066320 @default.
• W2004123655 creator A5033326660 @default.
• W2004123655 creator A5037412127 @default.
• W2004123655 creator A5037991551 @default.
• W2004123655 creator A5039560593 @default.
• W2004123655 creator A5043140898 @default.
• W2004123655 creator A5043470961 @default.
• W2004123655 creator A5046211758 @default.
• W2004123655 creator A5067252578 @default.
• W2004123655 creator A5071285241 @default.
• W2004123655 creator A5075102109 @default.
• W2004123655 creator A5077691716 @default.
• W2004123655 creator A5083025134 @default.
• W2004123655 creator A5083087923 @default.
• W2004123655 date "2010-04-01" @default.
• W2004123655 modified "2023-09-25" @default.
• W2004123655 title "677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL" @default.
• W2004123655 cites W1420630981 @default.
• W2004123655 cites W1514189093 @default.
• W2004123655 cites W1557741015 @default.
• W2004123655 cites W1860286105 @default.
• W2004123655 cites W1918606482 @default.
• W2004123655 cites W1965674043 @default.
• W2004123655 cites W1967449713 @default.
• W2004123655 cites W1974810481 @default.
• W2004123655 cites W1984031731 @default.
• W2004123655 cites W1987180459 @default.
• W2004123655 cites W1988675066 @default.
• W2004123655 cites W1990983378 @default.
• W2004123655 cites W2003955264 @default.
• W2004123655 cites W2005658600 @default.
• W2004123655 cites W2005875800 @default.
• W2004123655 cites W2007521294 @default.
• W2004123655 cites W2007686629 @default.
• W2004123655 cites W2040122586 @default.
• W2004123655 cites W2040734194 @default.
• W2004123655 cites W2040909450 @default.
• W2004123655 cites W2051686420 @default.
• W2004123655 cites W2054334976 @default.
• W2004123655 cites W2056164819 @default.
• W2004123655 cites W2057104738 @default.
• W2004123655 cites W2059724367 @default.
• W2004123655 cites W2061271065 @default.
• W2004123655 cites W2068813226 @default.
• W2004123655 cites W2079068389 @default.
• W2004123655 cites W2079745451 @default.
• W2004123655 cites W2080439368 @default.
• W2004123655 cites W2083451024 @default.
• W2004123655 cites W2083473946 @default.
• W2004123655 cites W2086075223 @default.
• W2004123655 cites W2089518544 @default.
• W2004123655 cites W2092714565 @default.
• W2004123655 cites W2093884797 @default.
• W2004123655 cites W2100201127 @default.
• W2004123655 cites W2100368880 @default.
• W2004123655 cites W2101581671 @default.
• W2004123655 cites W2102090981 @default.
• W2004123655 cites W2105130747 @default.
• W2004123655 cites W2107537216 @default.
• W2004123655 cites W2109490785 @default.
• W2004123655 cites W2110155536 @default.
• W2004123655 cites W2113069845 @default.
• W2004123655 cites W2117431306 @default.
• W2004123655 cites W2118055719 @default.
• W2004123655 cites W2125417601 @default.
• W2004123655 cites W2125859388 @default.
• W2004123655 cites W2126127142 @default.
• W2004123655 cites W2129268315 @default.
• W2004123655 cites W2130389194 @default.
• W2004123655 cites W2139295697 @default.
• W2004123655 cites W2148299252 @default.
• W2004123655 cites W2151014103 @default.
• W2004123655 cites W2156038471 @default.
• W2004123655 cites W2156675849 @default.
• W2004123655 cites W2162923066 @default.
• W2004123655 cites W2164578622 @default.
• W2004123655 cites W2170743542 @default.
• W2004123655 cites W2172253009 @default.
• W2004123655 doi "https://doi.org/10.1016/j.juro.2010.02.1076" @default.
• W2004123655 hasPublicationYear "2010" @default.
• W2004123655 type Work @default.
• W2004123655 sameAs 2004123655 @default.
• W2004123655 citedByCount "0" @default.
• W2004123655 crossrefType "journal-article" @default.
• W2004123655 hasAuthorship W2004123655A5007998286 @default.
• W2004123655 hasAuthorship W2004123655A5009433306 @default.
• W2004123655 hasAuthorship W2004123655A5024624058 @default.
• W2004123655 hasAuthorship W2004123655A5029066320 @default.
• W2004123655 hasAuthorship W2004123655A5033326660 @default.
• W2004123655 hasAuthorship W2004123655A5037412127 @default.
• W2004123655 hasAuthorship W2004123655A5037991551 @default.
• W2004123655 hasAuthorship W2004123655A5039560593 @default.
• W2004123655 hasAuthorship W2004123655A5043140898 @default.
• W2004123655 hasAuthorship W2004123655A5043470961 @default.
• W2004123655 hasAuthorship W2004123655A5046211758 @default.

• next